iShares Biotechnology ETF (IBB) News Today → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free IBB Stock Alerts $136.69 -0.60 (-0.44%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 10, 2024 | marketbeat.comWill the Biotech Sector Shift From Lagger to Leader?The biotech sector and its popular ETF, the iShares Biotechnology ETF NASDAQ: IBB, have lagged the overall market during the year, with its shares slightly red. However, in recent weeks, the sector has enjoyed a significant rally after bouncing off its uptrend support and now consolidating near several major Simple Moving Averages (SMA).May 10, 2024 | marketbeat.comWill the Biotech Sector Shift From Lagger to Leader? (IBB)The biotech sector has experienced a significant rally after bouncing off uptrend support and is now consolidating near major SMAs.May 10, 2024 | seekingalpha.comIGV: The Software ETF Will Eventually Share In The Love We're Now Giving To SemiconductorsMay 6, 2024 | marketbeat.comWhy Invest in Biotech Stocks (IBB)One fascinating sector to invest in is the biotech sector which includes companies involved in the research and development of therapeutics and vaccinesMay 2, 2024 | investing.comRisk On, Risk Off, or Risk Who Knows?May 1, 2024 | investing.comWhen Silver Looks Bad, It’s Usually a Sign of a BottomApril 30, 2024 | markets.businessinsider.comApril Showers On Wall Street: Miners, Utilities Emerge As Bright Spots In Gloomy MarketApril 28, 2024 | nasdaq.comJune 7th Options Now Available For iShares Trust - iShares Biotechnology ETF (IBB)April 19, 2024 | msn.com9 Best Biotech ETFs for 2024April 17, 2024 | nasdaq.comIBB Crosses Critical Technical IndicatorApril 10, 2024 | msn.comTop 10 best performing S&P 500 health care stocks of 2024April 8, 2024 | investing.comSemiconductors Steady, Biotech Stumbles: What's Next for These Sectors?April 3, 2024 | marketbeat.comBiotech Sector Nears Breakout: Will it Outperform in Q2?The popular iShares Biotechnology ETF NASDAQ: IBB has formed a bullish consolidation in the upper portion of its 52-week range, hinting at a significant sector-wide breakout.April 3, 2024 | marketbeat.comBiotech Sector Nears Breakout: Will it Outperform in Q2? (IBB)The Biotech sector ETF is consolidating in its upper range, indicating a potential sector breakout despite modest year-to-date gainsApril 2, 2024 | investing.comYields Up, US Dollar Up, Junk Bonds Tumble as New Quarter Kicks OffApril 1, 2024 | seekingalpha.comPBE: Biotech Could Be Next Big WinnerApril 1, 2024 | investing.comAre Retail Stocks Poised for Further Gains?March 26, 2024 | seekingalpha.comIBB: Let It RestMarch 24, 2024 | msn.comiShares Nasdaq Biotechnology ETF declares quarterly distribution of $0.1259March 19, 2024 | investorplace.com3 Biotech ETFs Overdue for a BounceMarch 18, 2024 | finance.yahoo.comIBB Apr 2024 139.500 callMarch 18, 2024 | finance.yahoo.comIBB Apr 2024 131.000 putMarch 18, 2024 | investing.comSilver, Gold Poised for Breakout? Key Levels to Watch for ConfirmationMarch 18, 2024 | finance.yahoo.comIBB Apr 2024 136.500 callMarch 16, 2024 | msn.comTwo Different Flavors of BiotechMarch 16, 2024 | finance.yahoo.comIBB Mar 2024 145.000 callMarch 16, 2024 | finance.yahoo.comIBB Mar 2024 131.000 putMarch 16, 2024 | finance.yahoo.comIBB Mar 2024 130.000 callMarch 16, 2024 | finance.yahoo.comIBB Mar 2024 134.000 callMarch 15, 2024 | finance.yahoo.comIBB Apr 2024 132.000 putMarch 15, 2024 | finance.yahoo.comIBB Apr 2024 138.000 putMarch 15, 2024 | finance.yahoo.comIBB Apr 2024 141.500 callMarch 13, 2024 | msn.com6 ways to diversify away from mega-cap growth after a monstrous market rally, according to a veteran chartmasterMarch 11, 2024 | finance.yahoo.comIBB Mar 2024 138.500 putMarch 9, 2024 | finance.yahoo.comIBB Mar 2024 121.000 putMarch 9, 2024 | finance.yahoo.comIBB Apr 2024 111.000 putMarch 9, 2024 | finance.yahoo.comIBB Mar 2024 122.000 putMarch 9, 2024 | finance.yahoo.comIBB Mar 2024 125.000 callMarch 9, 2024 | seekingalpha.comWhy Biotech Stocks May Be Ready For A RecoveryMarch 5, 2024 | finance.yahoo.comIBB Apr 2024 138.500 callMarch 5, 2024 | finance.yahoo.comIBB Apr 2024 129.000 putMarch 5, 2024 | finance.yahoo.comIBB Apr 2024 141.000 callMarch 4, 2024 | finance.yahoo.comIBB Mar 2024 139.000 putMarch 2, 2024 | finance.yahoo.comIBB Mar 2024 141.000 callMarch 2, 2024 | finance.yahoo.comIBB Mar 2024 120.000 putFebruary 29, 2024 | marketwatch.comThis biotech ETF sees ‘breakout’ while U.S. small-cap technology stocks lagFebruary 27, 2024 | finance.yahoo.comIBB Mar 2024 139.000 callFebruary 27, 2024 | finance.yahoo.comIBB Mar 2024 133.000 putFebruary 26, 2024 | finance.yahoo.comIBB Mar 2024 129.000 callFebruary 24, 2024 | finance.yahoo.comIBB Mar 2024 136.500 call Get iShares Biotechnology ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for IBB and its competitors with MarketBeat's FREE daily newsletter. Email Address Obama’s Forever Term [exposed] (Ad)America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision. Start streaming it now at no cost here IBB Media Mentions By Week IBB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IBB News Sentiment▼1.000.69▲Average Finance News Sentiment IBB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IBB Articles This Week▼03▲IBB Articles Average Week Get iShares Biotechnology ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for IBB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: VanEck Pharmaceutical ETF News Today VanEck Biotech ETF News Today Invesco S&P SmallCap Health Care ETF News Today ProShares Ultra Nasdaq Biotechnology News Today Principal Healthcare Innovators ETF News Today Invesco Nasdaq Biotechnology ETF News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IBB) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaProtect Your Bank Account Before It’s Too LateWeiss RatingsHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetryForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
